Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer

Conclusion</b> : There is no major difference of efficacy and safety between cetuximab given every 2 weeks and a weekly dosing regimen, in association with irinotecan. (Source: Journal of Cancer Research and Therapeutics) MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed – updated hourly from thousands of authoritative health and news sources.

Here is the original post:
Irinotecan associated with cetuximab given every 2 weeks versus cetuximab weekly in metastatic colorectal cancer

Related posts:

1. Cetuximab Plus Irinotecan in Pretreated Metastatic Colorectal Cancer Progressing on Irinotecan: The LABEL Study. Conclusion: Cetuximab in combination with irinotecan is active and tolerable...
2. Management of cutaneous side-effects of cetuximab therapy in patients with metastatic colorectal cancer Conclusion During the treatment with EGFRI, it is necessary to...
3. [Short-term efficacy of cetuximab combined with radiotherapy or chemotherapy on head and neck cancer: a report of 11 cases.] Conclusion: Cetuximab combined wthe either radiotherapy or chemotherapy are good...
4. Phase II study of the combination of cetuximab and weekly paclitaxel in the first-line treatment of patients with recurrent and/or metastatic squamous… CONCLUSION: The combination of cetuximab and weekly paclitaxel was active...
5. Cancer, arthritis, diabetes, even acne – is breast milk the new wonder cure? There's little doubt that breast milk helps keep babies healthy,...

Leave a comment

Name (required)

E-mail (required)

URI

Your Message